Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Federal health agencies including the NIH, FDA, and CDC laid off over 10,000 employees following a Supreme Court ruling.

Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

Infant vaccination rates improved from 2023 to 2024, but millions of infants still do not receive routine vaccination.

The CDC confirmed a nationwide uptick in COVID-19 cases, with increases seen in 25 states, suggesting a summer spike.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

HealthDay News — Seventy percent of U.S. adults would conduct a home test for suspected COVID-19, according to a study published online June 30 in JAMA Network Open.

Increased risk for all-cause and CVD mortality in OSA may be linked to a severe phenotype marked by objective excessive daytime sleepiness.

RFK Jr cancelled a meeting of the US Preventive Services Task Force, potentially interfering with their ability to make recommendations.

A resident of Northern Arizona recently died after being infected with the pneumonic plague, the first death in the US since 2007.